John W Smither New Amsterdam Pharma CO N.V. (NAMS) insider trading activity

Shares Held (Direct Ownership) 6.96K

n/a 3M change

n/a 12M change

Total Value Held N/A

John W Smither Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Date	Transaction	Value	Shares Traded	Shares Held	Form
Jan 07 2025	BUY Grant, award, or other acquisition	-	6,960 Added 50.0%	6,960 Ordinary Shares

Also insider at

ARQT

Arcutis Biotherapeutics, Inc. Healthcare

Chief Financial Officer

EFTR

eFFECTOR Therapeutics, Inc. Healthcare

Director

AMTI

Applied Molecular Transport Inc. Healthcare

Director

GNLX

GENELUX CORP

JWS

John W Smither

Solana Beach, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NAMS shares.

Notify only if

Value

Any

Insider Trading

Get notified when an New Amsterdam Pharma CO N.V. insider buys or sells NAMS shares.

Notify only if

Operation

Any

Value

Any

Type

P - Open market or private purchase×

S - Open market or private sale×

V - Transaction voluntarily reported earlier than required×

A - Grant, award, or other acquisition×

D - Sale (or disposition) back to the issuer×

F - Payment of exercise price or tax liability×

I - Discretionary transaction×

M - Exercise of conversion of derivative security×

C - Conversion of derivative security×

E - Expiration of short derivative position×

H - Expiration (or cancellation) of long derivative position with value received×

O - Exercise of out-of-the-money derivative securities×

X - Exercise of in-the-money or at-the-money derivatives securities×

G - Bona fide gift×

L - Small Acquisition×

W - Acquisition or disposition by will or laws×

Z - Deposit into or withdrawal from voting trust×

J - Other acquisition or disposition×

K - Transaction in equity swap or similar instrument×

U - Disposition due to a tender of shares in a change of control transaction×

20 item(s) selected

News

Receive news related to NewAmsterdam Pharma Co N.V.

Track Activities on NAMS

Account